Protein tyrosine phosphatase Shp2 deficiency in podocytes attenuates lipopolysaccharide-induced proteinuria

Abstract Podocytes are specialized epithelial cells that play a significant role in maintaining the integrity of the glomerular filtration barrier and preventing urinary protein leakage. We investigated the contribution of protein tyrosine phosphatase Shp2 to lipopolysaccharide (LPS)-induced renal i...

Full description

Bibliographic Details
Main Authors: Ming-Fo Hsu, Ahmed Bettaieb, Yoshihiro Ito, James Graham, Peter J. Havel, Fawaz G. Haj
Format: Article
Language:English
Published: Nature Portfolio 2017-03-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-017-00564-3
_version_ 1818856115030458368
author Ming-Fo Hsu
Ahmed Bettaieb
Yoshihiro Ito
James Graham
Peter J. Havel
Fawaz G. Haj
author_facet Ming-Fo Hsu
Ahmed Bettaieb
Yoshihiro Ito
James Graham
Peter J. Havel
Fawaz G. Haj
author_sort Ming-Fo Hsu
collection DOAJ
description Abstract Podocytes are specialized epithelial cells that play a significant role in maintaining the integrity of the glomerular filtration barrier and preventing urinary protein leakage. We investigated the contribution of protein tyrosine phosphatase Shp2 to lipopolysaccharide (LPS)-induced renal injury. We report increased Shp2 expression in murine kidneys and cultured podocytes following an LPS challenge. To determine the role of podocyte Shp2 in vivo, we generated podocyte-specific Shp2 knockout (pod-Shp2 KO) mice. Following administration of LPS, pod-Shp2 KO mice exhibited lower proteinuria and blood urea nitrogen concentrations than controls indicative of preserved filter integrity. In addition, renal mRNA and serum concentrations of inflammatory cytokines IL-1β, TNFα, INFγ and IL-12 p70 were significantly decreased in LPS-treated knockout mice compared with controls. Moreover, the protective effects of podocyte Shp2 deficiency were associated with decreased LPS-induced NF-κB and MAPK activation, nephrin phosphorylation and attenuated endoplasmic reticulum stress. These effects were recapitulated in differentiated E11 murine podocytes with lentiviral-mediated Shp2 knockdown. Furthermore, Shp2 deficient podocytes displayed reduced LPS-induced migration in a wound healing assay. These findings identify Shp2 in podocytes as a significant contributor to the signaling events following LPS challenge and suggest that inhibition of Shp2 in podocytes may present a potential therapeutic target for podocytopathies.
first_indexed 2024-12-19T08:19:22Z
format Article
id doaj.art-596de7c5fb144f74bc697024e074dc19
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-19T08:19:22Z
publishDate 2017-03-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-596de7c5fb144f74bc697024e074dc192022-12-21T20:29:25ZengNature PortfolioScientific Reports2045-23222017-03-017111310.1038/s41598-017-00564-3Protein tyrosine phosphatase Shp2 deficiency in podocytes attenuates lipopolysaccharide-induced proteinuriaMing-Fo Hsu0Ahmed Bettaieb1Yoshihiro Ito2James Graham3Peter J. Havel4Fawaz G. Haj5Department of Nutrition, University of California DavisDepartment of Nutrition, University of California DavisDepartment of Nutrition, University of California DavisDepartment of Nutrition, University of California DavisDepartment of Nutrition, University of California DavisDepartment of Nutrition, University of California DavisAbstract Podocytes are specialized epithelial cells that play a significant role in maintaining the integrity of the glomerular filtration barrier and preventing urinary protein leakage. We investigated the contribution of protein tyrosine phosphatase Shp2 to lipopolysaccharide (LPS)-induced renal injury. We report increased Shp2 expression in murine kidneys and cultured podocytes following an LPS challenge. To determine the role of podocyte Shp2 in vivo, we generated podocyte-specific Shp2 knockout (pod-Shp2 KO) mice. Following administration of LPS, pod-Shp2 KO mice exhibited lower proteinuria and blood urea nitrogen concentrations than controls indicative of preserved filter integrity. In addition, renal mRNA and serum concentrations of inflammatory cytokines IL-1β, TNFα, INFγ and IL-12 p70 were significantly decreased in LPS-treated knockout mice compared with controls. Moreover, the protective effects of podocyte Shp2 deficiency were associated with decreased LPS-induced NF-κB and MAPK activation, nephrin phosphorylation and attenuated endoplasmic reticulum stress. These effects were recapitulated in differentiated E11 murine podocytes with lentiviral-mediated Shp2 knockdown. Furthermore, Shp2 deficient podocytes displayed reduced LPS-induced migration in a wound healing assay. These findings identify Shp2 in podocytes as a significant contributor to the signaling events following LPS challenge and suggest that inhibition of Shp2 in podocytes may present a potential therapeutic target for podocytopathies.https://doi.org/10.1038/s41598-017-00564-3
spellingShingle Ming-Fo Hsu
Ahmed Bettaieb
Yoshihiro Ito
James Graham
Peter J. Havel
Fawaz G. Haj
Protein tyrosine phosphatase Shp2 deficiency in podocytes attenuates lipopolysaccharide-induced proteinuria
Scientific Reports
title Protein tyrosine phosphatase Shp2 deficiency in podocytes attenuates lipopolysaccharide-induced proteinuria
title_full Protein tyrosine phosphatase Shp2 deficiency in podocytes attenuates lipopolysaccharide-induced proteinuria
title_fullStr Protein tyrosine phosphatase Shp2 deficiency in podocytes attenuates lipopolysaccharide-induced proteinuria
title_full_unstemmed Protein tyrosine phosphatase Shp2 deficiency in podocytes attenuates lipopolysaccharide-induced proteinuria
title_short Protein tyrosine phosphatase Shp2 deficiency in podocytes attenuates lipopolysaccharide-induced proteinuria
title_sort protein tyrosine phosphatase shp2 deficiency in podocytes attenuates lipopolysaccharide induced proteinuria
url https://doi.org/10.1038/s41598-017-00564-3
work_keys_str_mv AT mingfohsu proteintyrosinephosphataseshp2deficiencyinpodocytesattenuateslipopolysaccharideinducedproteinuria
AT ahmedbettaieb proteintyrosinephosphataseshp2deficiencyinpodocytesattenuateslipopolysaccharideinducedproteinuria
AT yoshihiroito proteintyrosinephosphataseshp2deficiencyinpodocytesattenuateslipopolysaccharideinducedproteinuria
AT jamesgraham proteintyrosinephosphataseshp2deficiencyinpodocytesattenuateslipopolysaccharideinducedproteinuria
AT peterjhavel proteintyrosinephosphataseshp2deficiencyinpodocytesattenuateslipopolysaccharideinducedproteinuria
AT fawazghaj proteintyrosinephosphataseshp2deficiencyinpodocytesattenuateslipopolysaccharideinducedproteinuria